Related Experiment Videos
Modification of peptide interaction with MHC creates TCR partial agonists
Kelli R Ryan1, Lisa K McNeil, Chinh Dao
1Graduate Program in Immunology and Molecular Pathogenesis, Department of Microbiology and Immunology, Emory University, 1510 Clifton Rd. Atlanta, GA 30322, USA.
Cellular Immunology
|March 31, 2004
Summary
Researchers created T-cell receptor (TCR) partial agonists by modifying peptide-MHC interactions. This novel approach alters peptide affinity for MHC class II, generating peptides that stimulate cytolytic function without proliferation.
Area of Science:
- Immunology
- Molecular Biology
- T-cell Receptor (TCR) Signaling
Background:
- T-cell receptor (TCR) agonists are crucial for immune responses.
- Understanding TCR-peptide-MHC interactions is key to modulating T-cell activity.
- Altered peptide ligands traditionally focus on TCR contact residues.
Purpose of the Study:
- To develop a novel method for creating TCR partial agonists.
- To investigate the effect of manipulating peptide-MHC interactions on T-cell responses.
- To explore whether altering MHC anchor residues can generate TCR partial agonists.
Main Methods:
- Exchanged MHC anchor residues of I-E(k)-restricted hemoglobin (64-76) and moth cytochrome c (88-103) peptides with those from CLIP.
- Created antigenic peptides with altered affinity for MHC class II.
- Assessed T-cell responses, specifically cytolytic function and proliferation, to the modified peptides.
Main Results:
- Identified several low-affinity peptides acting as TCR partial agonists.
- These partial agonists stimulated cytolytic function but not proliferation.
- Methionine substitutions in hemoglobin and moth cytochrome c peptides created partial agonists for specific T-cell clones, demonstrating conserved effects across different antigens and TCR specificities.
Conclusions:
- Altering MHC anchor residues of immunogenic peptides is an effective strategy for generating TCR partial agonists.
- This method provides a novel approach to T-cell modulation, distinct from traditional altered peptide ligand strategies.
- Peptide-MHC interaction manipulation offers a powerful tool for creating specific T-cell responses.